The Patient Access & Affordability Project is funded through a combination of unrestricted grants and membership. Our research and commentary calendar is determined internally by the Patient Access & Affordability Project leadership and our independent advisors who are not supporting member appointees.

The Project receives support from pharmaceutical and health insurance companies for our annual Policy Roundtable and educational webinars. Current members include:

  • AbbVie
  • Gilead Sciences
  • Janssen
  • Pfizer
  • PTC Therapeutics
  • Sarepta
  • Vertex

If you are interested in learning more about how to become a member, please contact Joelle Sokolic at